ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/28/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. SPCX
8. DRI
9. NVDA
10. FDXF

Go back to ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program

Feuerstein Takes Shot at ImmunoCellular Therapeutics (IMUC) After Shares Jump

December 13, 2017 4:30 PM EST

STAT's Adam Feuerstein took a shot at ImmunoCellular Therapeutics (NYSE: IMUC) on twitter after shares jumped following a press release titled, "ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program"

Feuerstein responded:... More